Short Interest in Acutus Medical, Inc. (NASDAQ:AFIB) Decreases By 14.2%

Acutus Medical, Inc. (NASDAQ:AFIB) was the recipient of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 845,200 shares, a decrease of 14.2% from the March 15th total of 984,700 shares. Currently, 4.5% of the shares of the stock are short sold. Based on an average daily volume of 2,250,000 shares, the short-interest ratio is currently 0.4 days.

Institutional Investors Weigh In On Acutus Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its stake in shares of Acutus Medical by 70.1% in the 3rd quarter. Vanguard Group Inc. now owns 1,142,170 shares of the company’s stock valued at $1,005,000 after acquiring an additional 470,719 shares during the last quarter. State Street Corp lifted its stake in shares of Acutus Medical by 11.0% in the 1st quarter. State Street Corp now owns 430,865 shares of the company’s stock valued at $599,000 after acquiring an additional 42,578 shares during the last quarter. Renaissance Technologies LLC bought a new position in shares of Acutus Medical in the 1st quarter valued at $499,000. AQR Capital Management LLC lifted its stake in shares of Acutus Medical by 844.0% in the 2nd quarter. AQR Capital Management LLC now owns 174,352 shares of the company’s stock valued at $195,000 after acquiring an additional 155,883 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC lifted its stake in shares of Acutus Medical by 1,065.1% in the 1st quarter. Schonfeld Strategic Advisors LLC now owns 170,100 shares of the company’s stock valued at $128,000 after acquiring an additional 155,500 shares during the last quarter. 56.91% of the stock is currently owned by institutional investors.

Acutus Medical Price Performance

NASDAQ AFIB opened at $0.18 on Friday. The business has a fifty day moving average price of $0.19 and a two-hundred day moving average price of $0.29. The company has a debt-to-equity ratio of 1.10, a current ratio of 2.44 and a quick ratio of 2.22. Acutus Medical has a fifty-two week low of $0.16 and a fifty-two week high of $1.09. The stock has a market capitalization of $5.20 million, a PE ratio of -0.14 and a beta of 0.19.

About Acutus Medical

Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.